Elucidating the Effect of Extreme Delta Brush Pattern in Anti-N-Methyl-D- Aspartate (NMDA) Receptor Encephalitis
![Encephalitis](https://sciaxis.org/wp-content/uploads/2021/11/3d-male-figure-with-pixelated-brain-depicting-mental-health-problems.jpg)
![Encephalitis](https://sciaxis.org/wp-content/uploads/2021/11/3d-male-figure-with-pixelated-brain-depicting-mental-health-problems.jpg)
Introduction Anti-N-methyl-d-aspartate (Anti-NMDA) encephalitis (ANMDARE), an autoimmune initially manifests as viral prodrome progressing to psychiatric symptoms. These lead to movement disorders and/or seizures ultimately progressing to decreased level of consciousness. The extreme delta brush is a pattern usually observed in frontotemporal regions of premature infants. This pattern normally goes off upon anti-epileptic treatment, but it […]
Next generation DBS system for movement disorders receives Green Flag from FDA
![Next generation DBS system for movement disorders receives Green Flag from FDA](https://sciaxis.org/wp-content/uploads/2021/07/human-nervous-system_53876-90445-1024x682.jpg)
![Next generation DBS system for movement disorders receives Green Flag from FDA](https://sciaxis.org/wp-content/uploads/2021/07/human-nervous-system_53876-90445-1024x682.jpg)
The FDA recently approved Medtronic’s technologically advanced deep brain stimulation (DBS) system that has been designed to target motor symptoms in Parkinson’s disease, dystonia or essential tremor in a precise manner. The SenSight Directional Lead System for DBS therapy integrates the sensing capability that allows real-time monitoring of brain signals and a directional lead that […]